Article Versions Notes

Aljohani H, Anbarserry D, Mosli M, Ujaimi A, Bakhshwin D, Elango R, Alharthi S. High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia. Biomedicines. 2025; 13(2):459. https://doi.org/10.3390/biomedicines13020459

Aljohani, Hanin, Doaa Anbarserry, Mahmoud Mosli, Amani Ujaimi, Duaa Bakhshwin, Ramu Elango, and Sameer Alharthi. 2025. "High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia" Biomedicines 13, no. 2: 459. https://doi.org/10.3390/biomedicines13020459

Aljohani, H., Anbarserry, D., Mosli, M., Ujaimi, A., Bakhshwin, D., Elango, R., & Alharthi, S. (2025). High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia. Biomedicines, 13(2), 459. https://doi.org/10.3390/biomedicines13020459